Prediction model for mild cognitive impairment in patients with type 2 diabetes using the autonomic function test

被引:0
|
作者
Kang, Heeyoung [1 ]
Kim, Juhyeon [2 ]
Kim, Minkyeong [2 ]
Kim, Jin Hyun [3 ]
Roh, Gu Seob [4 ]
Kim, Soo Kyoung [5 ]
机构
[1] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Inst Med Sci, Coll Med,Dept Neurol, Jinju 52727, South Korea
[2] Gyeongsang Natl Univ Hosp, Dept Neurol, Jinju, South Korea
[3] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea
[4] Gyeongsang Natl Univ, Inst Med Sci, Coll Med, Dept Anat, Jinju, South Korea
[5] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Inst Med Sci, Coll Med,Dept Internal Med, Jinju 52727, South Korea
基金
新加坡国家研究基金会;
关键词
Diabetes mellitus; Mild cognitive impairment; Autonomic nervous system; Heart rate variability; DEMENTIA; MELLITUS; ASSOCIATION; RISK; MOCA;
D O I
10.1007/s10072-024-07451-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveType 2 diabetes mellitus (T2DM) is a risk factor for cognitive impairment, and reduced heart rate variability (HRV) has been correlated with cognitive impairment in elderly individuals. This study investigated risk factors and validated a predictive model for mild cognitive impairment (MCI) in patients with T2DM using an autonomic function test.MethodsPatients with T2DM, 50-85 years of age, who attended the diabetes clinic at Gyeongsang National University Hospital between March 2018 and December 2019, were included. A total of 201 patients had been screened; we enrolled 124 patients according to the inclusion and exclusion criteria in this study. Cognitive function was assessed using the Montreal Cognitive Assessment-Korean version (MOCA-K); MCI was defined as a total MOCA-K score <= 23. Risk factors for MCI in patients with T2DM, including demographic- and diabetes-related factors, and autonomic function test results, were analyzed. Based on multivariate logistic regression, a nomogram was developed as a prediction model for MCI.ResultsThirty-nine of 124 patients were diagnosed with MCI. Age, education, and decreased cardiovagal function were associated with a high risk for MCI, with cardiovagal function exerting the greatest influence. However, diabetes-related factors, such as glycemic control, duration of diabetes, or medications, were not associated with the risk for MCI. The nomogram demonstrated excellent discrimination (area under the curve, 0.832) and was well calibrated.ConclusionApproximately one-third of patients had MCI; as such, carefully evaluating cognitive function in elderly T2DM patients with reduced HRV is important to prevent progression to dementia.
引用
收藏
页码:3757 / 3766
页数:10
相关论文
共 50 条
  • [21] Type 2 Diabetes Is an Independent Risk Factor for Dementia Conversion in Mild Cognitive Impairment Patients
    Ciudin, Andreea
    Simo-Servat, Olga
    Hernandez Pascual, Cristina
    Boada, Merce
    Simo, Rafael
    DIABETES, 2016, 65 : A386 - A386
  • [22] Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
    Salama, Iman I.
    Sami, Samia M.
    Abdellatif, Ghada A.
    Mohsen, Amira
    Rasmy, Hanaa
    Kamel, Solaf Ahmed
    Ibrahim, Mona Hamed
    Mostafa, Mona
    Fouad, Walaa A.
    Raslan, Hala M.
    PLOS ONE, 2020, 15 (07):
  • [23] Association between the neutrophil to lymphocyte ratio and mild cognitive impairment in patients with type 2 diabetes
    Yu, Zi-Wei
    Wang, Ying
    Li, Xin
    Tong, Xue-Wei
    Zhang, Yi-Tong
    Gao, Xin-Yuan
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 (06) : 1339 - 1345
  • [24] Effects of Mediterranean Diet and Resistance Training on Mild Cognitive Impairment in Patients with Type 2 Diabetes
    Kuang, Y. J.
    Li, D. H.
    Zheng, X.
    Wang, X. X.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S665 - S666
  • [25] EVALUATION OF MILD COGNITIVE IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES REGARDING PRIMARY CARE IN TURKEY
    Salduz, Zeyneb Irem Yuskel
    Özder, Aclan
    ACTA MEDICA MEDITERRANEA, 2023, 39 (02): : 609 - 614
  • [26] Association of plasma zinc and copper levels with mild cognitive impairment in patients with type 2 diabetes
    Jiao, Yang
    Zhang, Xing
    Duan, Lian
    Cheng, Ruijie
    Yang, Ning
    Peng, Zhao
    Li, Ben
    Xu, Lu
    Chen, Wenwen
    Chen, Jingrong
    Liu, Yanchao
    Yan, Hong
    FRONTIERS IN NUTRITION, 2025, 12
  • [27] Type 2 diabetes is an independent risk factor for dementia conversion in mild cognitive impairment patients
    Ciudin, A.
    Espinosa, A.
    Ruiz, A.
    Alegret, M.
    Hernandez, C.
    Boada, M.
    Simo, R.
    DIABETOLOGIA, 2013, 56 : S523 - S523
  • [28] Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment
    Albai, Oana
    Frandes, Mirela
    Timar, Romulus
    Roman, Deiana
    Timar, Bogdan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 167 - 175
  • [29] Rosiglitazone and cognitive stability in older persons with type 2 diabetes and mild cognitive impairment
    Abbatecola, A. M.
    Paolisso, G.
    DIABETOLOGIA, 2009, 52 : S67 - S67
  • [30] Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
    Abbatecola, Angela M.
    Lattanzio, Fabrizia
    Molinari, Anna M.
    Cioffi, Michele
    Mansi, Luigi
    Rambaldi, Pierfrancesco
    DiCioccio, Luigi
    Cacciapuoti, Federico
    Canonico, Raffaele
    Paolisso, Giuseppe
    DIABETES CARE, 2010, 33 (08) : 1706 - 1711